Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome

J Dermatol. 2014 Mar;41(3):258-61. doi: 10.1111/1346-8138.12410. Epub 2014 Feb 10.

Abstract

Netherton syndrome (NS) is a rare autosomal recessive disorder which is caused by mutations in the SPINK5 gene encoding the serine-protease inhibitor LEKTI. Characteristic symptoms of NS include erythroderma with diffuse desquamation, hair abnormalities and atopic manifestations. Here, we report two Japanese patients with NS, one of whom had a novel mutation in the SPINK5 gene which leads to p.C367Lfs*3. The upregulation of interleukin-33 (IL-33) was evident in basal and thickened lower spinous layers of the epidermis in those cases. This suggests that IL-33 may be involved in the pathophysiology of NS as well as in atopic dermatitis.

Keywords: Netherton syndrome; SPINK5; atopic dermatitis; interleukin-33; mutation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epidermis / metabolism*
  • Epidermis / pathology
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Interleukin-33
  • Interleukins / metabolism*
  • Netherton Syndrome / genetics
  • Netherton Syndrome / metabolism*
  • Netherton Syndrome / pathology
  • Proteinase Inhibitory Proteins, Secretory / genetics
  • Serine Peptidase Inhibitor Kazal-Type 5
  • Up-Regulation

Substances

  • IL33 protein, human
  • Interleukin-33
  • Interleukins
  • Proteinase Inhibitory Proteins, Secretory
  • SPINK5 protein, human
  • Serine Peptidase Inhibitor Kazal-Type 5